HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Umang Shah Selected Research

N(6)- (4- amino- 3- iodobenzyl)adenosine- 5'- N- methyluronamide

1/2022Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Umang Shah Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 08/2015
4Breast Neoplasms (Breast Cancer)
01/2022 - 08/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2017
1Lung Neoplasms (Lung Cancer)
01/2022
1Hyperplasia
01/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Diabetes Mellitus
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2017
1Liposarcoma
04/2017
1Gambling (Pathological Gambling)
01/2017
1Botulism
09/2015
1Miller Fisher Syndrome (Fisher Syndrome)
09/2015
1Guillain-Barre Syndrome
09/2015
1Disease Progression
09/2015
1Hypertension (High Blood Pressure)
02/2014
1Glioma (Gliomas)
04/2013
1Nausea
04/2013
1Diarrhea
04/2013
1Seizures (Absence Seizure)
04/2013
1Constipation
04/2013
1Vomiting
04/2013
1Brain Edema (Cerebral Edema)
04/2013
1Mental Disorders (Mental Disorder)
04/2013
1Venous Thromboembolism
04/2013

Drug/Important Bio-Agent (IBA)

2FlavonoidsIBA
01/2022 - 01/2022
2Aromatase (CYP19)IBA
01/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
2EnzymesIBA
01/2022 - 01/2020
2Estrogens (Estrogen)FDA Link
01/2022 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2020
2AnthracyclinesIBA
04/2017 - 08/2015
2eribulinFDA Link
04/2017 - 08/2015
2taxaneIBA
04/2017 - 08/2015
1Aromatase InhibitorsIBA
01/2022
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2022
1N(6)- (4- amino- 3- iodobenzyl)adenosine- 5'- N- methyluronamideIBA
01/2022
1LigandsIBA
01/2022
1AlkaloidsIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1artemisinin (artemisinine)IBA
01/2021
1Testosterone PropionateFDA Link
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2020
1Guanidine (Guanidine Nitrate)FDA Link
01/2018
1Biological ProductsIBA
12/2017
1Methamphetamine (Desoxyn)FDA LinkGeneric
01/2017
1Heroin (Diamorphine)IBA
01/2017
1Botulinum AntitoxinIBA
09/2015
1Type A Botulinum Toxins (Botox)FDA Link
09/2015
1Intravenous Immunoglobulins (IVIG)FDA Link
09/2015

Therapy/Procedure

4Therapeutics
01/2022 - 02/2014
1Drug Therapy (Chemotherapy)
04/2013